key: cord-0913662-xl3519jo authors: Yan, Kexin; Dumenil, Troy; Tang, Bing; Le, Thuy T.; Bishop, Cameron; Suhrbier, Andreas; Rawle, Daniel J. title: ACE2-independent SARS-CoV-2 infection and mouse adaption emerge after passage in cells expressing human and mouse ACE2 date: 2022-03-31 journal: bioRxiv DOI: 10.1101/2021.12.16.473063 sha: 686782c8044de4514d42f6eecc14c13061cae97c doc_id: 913662 cord_uid: xl3519jo Human ACE2 (hACE2) is the key cell attachment and entry receptor for SARS-CoV-2, with the original SARS-CoV-2 isolates unable to use mouse ACE2 (mACE2). Herein we describe a new system for generating mouse-adapted SARS-CoV-2 in vitro by serial passaging virus in co-cultures of cell lines expressing hACE2 and mACE2. Mouse-adapted viruses emerged with up to five amino acid changes in the spike protein, all of which have been seen in human isolates. Mouse-adapted viruses replicated to high titers in C57BL/6J mouse lungs and nasal turbinates, and caused severe lung histopathology. One mouse-adapted virus was also able to replicate efficiently in ACE2-negative cell lines, with ACE2-independent entry by SARS-CoV-2 representing a new biology for SARS-CoV-2 that has potential widespread implications for disease and intervention development. Human ACE2 (hACE2) is the key cell attachment and entry receptor for SARS-CoV-2, with the 23 original SARS-CoV-2 isolates unable to use mouse ACE2 (mACE2). Herein we describe a new 24 system for generating mouse-adapted SARS-CoV-2 in vitro by serial passaging virus in co- 25 cultures of cell lines expressing hACE2 and mACE2. Mouse-adapted viruses emerged with up 26 to five amino acid changes in the spike protein, all of which have been seen in human isolates. 27 Mouse-adapted viruses replicated to high titers in C57BL/6J mouse lungs and nasal turbinates, 28 and caused severe lung histopathology. One mouse-adapted virus was also able to replicate 29 efficiently in ACE2-negative cell lines, with ACE2-independent entry by SARS-CoV-2 30 representing a new biology for SARS-CoV-2 that has potential widespread implications for 31 disease and intervention development. To investigate the process of mouse adaptation, SARS-CoV-2QLD02 was passaged in co-cultures 83 of HEK293T-hACE2 and HEK293T-mACE2, or HEK293T-mACE2 N31K/H353K and HEK293T-84 mACE2 cells, followed by passage in HEK293T-mACE2 cells (Fig. 1a . After 4 co-culture 85 passages, no viruses emerged that were able to replicate efficiently in HEK293T-mACE2 cells 86 (Fig. 1b, Passage 4) . However, after 9 co-culture passages, 5 viruses (MA1-5) demonstrated a 87 clear ability to replicate in HEK293T-mACE2 cells (Fig. 1b, Passage 9 ). As expected, SARS-88 CoV-2QLD02 did not replicate in HEK293T-mACE2 cells (Fig. 1b) . All 5 MA viruses showed 89 overt cytopathic effects (CPE) in HEK293T-mACE2 cells 2 days after infection (Fig. 1c) . 90 Importantly, these viruses were also able to replicate in lungs of wild-type C57BL/6J mice after 91 intrapulmonary inoculation (via the intranasal route) with 1.5×10 4 CCID50 per mouse (Fig. 1d) . MA1 and MA2 showed the highest lung titers, replicating to above 10 6 CCID50/g (Fig. 1d) . As 93 expected SARS-CoV-2QLD02 was unable to replicate in C57BL/6J mice (Fig. 1d) . The co-culture 94 and in vitro passaging of SARS-CoV-2QLD02 thus generated five viruses able to replicate in wild-95 type mice. In vitro growth kinetics of MA1 and MA2 were studied in more detail using stock virus 113 derived from infected mouse lungs and prepared in HEK293T-mACE2 cells (Fig. 1a) . As 114 expected, MA1 and MA2, as well as SARS-CoV-2QLD02, and Alpha and Beta strain viruses, all 115 replicated in HEK293T-hACE2 cells (Fig. 3a) . MA1, MA2 and Alpha, Beta, and Omicron strain Perhaps of interest, given the postulated rodent origins of Omicron 24,25 , our Omicron isolate 119 replicated more efficiently in HEK293T-mACE2 than in HEK293T-hACE2 cells (Fig. 3a, b) . 120 Remarkably, when replication was examined in control untransduced HEK293T cells, 121 both MA1 and MA2 showed significant replication, with MA1 replicating to ≈8 log10CCID50/ml 122 in 2 days (Fig. 3c) . None of the other viruses were able to replicate efficiently in untransduced 123 HEK293T cells (Fig. 3c) , consistent with previous reports 2,27,28 . Replication was also tested in a In contrast, MA2 and SARS-CoV-2QLD02 were unable to replicate in any of these cell lines ( Fig. 128 3d-i); the SARS-CoV-2QLD02 results are consistent with previous reports 2,29-32 . Overall, the data 129 suggests ACE2-independent infection by MA1 is robust across multiple cell lines and is 130 functional, at least in vitro, across 4 different species (human, mouse, hamster and pig). Mouse-to-mouse (C57BL/6J to K18-hACE2) transmission was not seen for either MA1 164 or MA2 ( Supplementary Fig. 9a,b) . Such transmission has been reported for K18-hACE2 to CoV-2 to jump species 2,12-14,16,17 . The ability to infect cells in an ACE2-independent manner, would appear to require the 222 E484D substitution, identified herein and previously 26 . This substitution has been identified in 223 multiple human isolates, in all variants of concern and in a large range of geographical locations 224 around the world ( Supplementary Fig. 11 ). Omicron has an E484A substitution in this position, 225 with Omicron requiring ACE2 expression for infection (Fig. 3) Supplementary Fig. 5c ). The concept that Omicron might have arisen via rodents 24,54 is perhaps supported by the 243 observation that Omicron replicated more efficiently in mACE2-expressing cells when compared 244 with hACE2-expressing cells (Fig. 3a,b) . Omicron binding to mACE2 is significantly higher 245 than Alpha and Beta variants, which are also able to use mACE2 as a receptor 55 . Increased 246 mACE2-binding by Omicron may involve the Q493R, Q498R and N501Y substitutions (Fig. 2c, 247 Omicron), given these changes are selected in mouse-adapted viruses 12-15,17 . Our MA viruses 248 have Q493R, Q498H and N501T substitutions ( Fig. 2c; Supplementary Fig. 1) , with modeling 249 suggesting Q493R and Q498H increase mACE2 binding ( Supplementary Fig. 2) . Finally, like Lentivirus encoding hACE2, mACE2 or mACE2 N31K/H353K were produced in HEK293T cells by 359 plasmid transfection and were used to transduce HEK293T cells, as described previously 2 . HEK293T-hACE2 or HEK293T-mACE2 N31K/H353K were mixed with equal cell numbers of 361 HEK293T-mACE2, and 500,000 cells (i.e. 250,000 HEK293T-hACE2 or mACE2 N31K/H353K + 362 250,000 HEK293T-mACE2) were seeded in 6 well plates overnight. Co-cultures were infected 363 with SARS-CoV-2 at MOI≈0.1. Every 3-4 days, supernatant was collected and centrifuged at 364 2000 x g at 4°C for 5 min, and 200 µl was added to fresh co-cultures and the remaining was 365 stored at -80°C. This was performed a total of 9 times before 1 ml was passaged on to A new coronavirus associated with human respiratory disease in China ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping 465 of receptor interactions ACE2 binding is an ancestral and evolvable trait of sarbecoviruses Discovery of a rich gene pool of bat SARS-related coronaviruses provides new 470 insights into the origin of SARS coronavirus SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 473 elicited neutralization and requires ACE2 for infection. medRxiv Emerging SARS-CoV-2 variants expand species tropism to murines Animal models for COVID-19 Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and 480 Non-human Primates A versatile reverse genetics platform for SARS-CoV-2 and other positive-483 strand RNA viruses Mouse models of COVID-19 recapitulate inflammatory pathways rather than 485 gene expression. bioRxiv SARS-CoV-2 Omicron virus causes attenuated disease in mice and 487 hamsters A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in 489 Standard Laboratory Mice SARS-CoV-2 Rapidly Adapts in Aged BALB/c Mice and Induces Typical Pneumonia Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in 494 mice Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower 498 respiratory tract of BALB/c and C57BL/6J mice A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures SARS-CoV-2 Neutralizing Antibodies Surveillance and control of SARS-CoV-2 in mustelids: An 506 evolutionary perspective An alphavirus replicon-based vaccine expressing a stabilized Spike antigen 508 induces protective immunity and prevents transmission of SARS-CoV-2 between cats. npj 509 Vaccines 6 CoV-2 due to improved ACE2 receptor binding in mink SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus 514 virginianus) SARS-CoV-2 infection and transmission in the North American deer mouse Where did Omicron come from? Three key theories. The hunt for the origins of 519 omicron Evidence for a mouse origin of the SARS-CoV-2 Omicron variant Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human 523 airway cell Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary 527 and bronchial epithelial cells KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and Kidney. medRxiv SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a 531 Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 534 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory 535 studies of COVID-19: an observational study TMEM41B is a host factor required for the replication of diverse 538 coronaviruses including SARS-CoV-2 The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned 541 towards temperature and proteases of the human airways COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice 544 that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge SARS-CoV-2 causes lung infection without severe disease in human ACE2 547 knock-in mice SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary 551 nasal epithelial cultures and efficiently uses the endosomal route of entry. bioRxiv Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters. 554 bioRxiv Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close 556 Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice The furin cleavage site in the SARS-CoV-2 spike protein is required for 559 transmission in ferrets Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory 564 Syndrome Coronavirus 2 Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High 567 BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 569 infection COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ 571 neutrophils and CD14+ monocytes Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the 576 Screening of Compounds Inhibiting Viral Replication Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or 579 Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2 CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in 586 human airway cells Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and 588 fusogenicity Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. 590 Nature Evidence for a mouse origin of the SARS-CoV-2 Omicron variant Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic 594 shift. bioRxiv More than 50 long-term effects of COVID-19: a systematic review and meta-596 analysis Pathological sequelae of long-haul COVID Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory 600 mediator production Complete removal of mycoplasma from 602 viral preparations using solvent extraction Lethal infection of K18-hACE2 mice infected with severe acute respiratory 605 syndrome coronavirus A quality control tool for high throughput sequence data Cutadapt removes adapter sequences from high-throughput sequencing reads STAR: ultrafast universal RNA-seq aligner Integrative genomics viewer The Sequence Alignment/Map format and SAMtools GENCODE: the reference human genome annotation for The ENCODE Project RSEM: accurate transcript quantification from RNA-Seq data with or 619 without a reference genome Data, disease and diplomacy: GISAID's innovative contribution to 622 global health Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with 624 receptor ACE2 revealed by cryo-EM least two MA viruses. b Amino acids changes and deletions in any of the MA viruses 669 shown on the structure of SARS-CoV-2QLD02 spike bound to hACE2 (PDB: 7DF4) GISAID n -number of GISAID submissions that contain this change; GISAID % -percentage 673 of all GISAID submissions with this change Match of amino acid changes in MA viruses with hallmark changes in variants of concern (green 676 -exact match, blue -conservative, brown -non-conservative change) Statistics by t-test. c As for (a) for the 695 indicated tissues. d-g IHC using an anti-SARS-CoV-2 spike monoclonal antibody and lungs 696 taken on day 2 after infection of C57BL/6J mice with MA1. Images are representative of lung 697 sections from 4 mice. Dark brown staining (Nova Red) indicates infected cells, often with the 698 expected, clearly discernable, cytoplasmic staining pattern Statistics by t-tests, with data from the 3 time points for infected mice combined. d High 711 magnification image showing bronchus from uninfected mice (left) and MA1 infected mice 712 (right) on day 4 post infection The latter shows lung consolidation and loss of 715 alveolar air spaces, as well as pulmonary edema (dotted ovals, bottom right). f High 716 magnification images of uninfected lungs (top) and in MA1 The latter shows dense cellular infiltrate RNA-Seq comparison of MA1 infected C57BL/6J versus SARS-CoV-2QLD02 RNA-Seq was performed on mouse lungs 4 dpi for MA1 746 infection of C57BL/6J mice, and SARS-CoV-2QLD02 infection of K18-hACE2 mice. DEGs (n = 747 1027 for C57BL/6J, n = 1349 for K18-hACE2) were analyzed by Ingenuity Pathway Analysis, 748 and z-scores for significant UpStream Regulators (a) or Diseases and Functions (b) were plotted 749 with C57BL/6J+MA1 on x-axis and K18-hACE2+QLD02 on the y-axis. Statistics by Pearson 750 correlations Annotations outside the 95% confidence limits are colored in red. Selected annotations are 752 labelled (red text). Full data sets are